A cluster of Candida glabrata isolates recovered from seven patients in an intensive care unit over a 10-week period were compared with a collection of isolates from six epidemiologically distinct outpatients and a reference strain by several DNA typing methods. Restriction enzyme analysis with HinfI distinguished 13 strains from the 14 sources and was the method of choice. Pulsed-field gel electrophoresis and random amplification of polymorphic DNA both detected nine types from the 14 sources; however, the results of these two methods did not always correlate. These methods demonstrated that five of the seven patients had distinguishable strains and that cross-infection was unlikely.
Candida glabrata is being recovered with increasing frequency from clinical specimens; for example, Horowitz et al. (5) reported a significant increase in instances of isolation of this yeast species in cases of vaginal candidosis over the last 30 years. This increase may be due in part to the selection of resistant organisms, including C. glabrata, by current antifungal agents, especially the azoles (4), though a recent study in a cancer center over 5 years found no increase in the instances of isolation of Candida species other than Candida albicans, despite the increasing use of antifungal agents (10) .
Few outbreaks caused by C. glabrata have been reported. A cluster of C. glabrata infections that took place in an adult leukemia unit and that was evaluated by restriction enzyme analysis (REA) was deemed to constitute an outbreak attributable to a common strain (11) . Further investigation by pulsed-field gel electrophoresis (PFGE) revealed that the outbreak was not of the magnitude originally claimed (9) . Thus, it may be necessary to employ several different typing methods to obtain optimal strain delineation.
In this paper, we report on the isolation of C. glabrata from a number of patients in an intensive care unit (ICU) within a short period of time and the techniques used to investigate the possibility that this appearance represented an outbreak.
MATERIALS AND METHODS
Epidemiology. C. glabrata was isolated from seven patients in the ICU over a period of 10 weeks. This species had not been isolated in the preceeding 9 weeks and was not isolated in the subsequent 7 weeks, and on average, only two isolates a month were recovered from the ICU throughout the following 9 months. Each of the seven patients was present in the ICU with at least one of the other six patients, and none of the patients developed proven fungemia. Patients 1 and 7 did not receive any systemic antifungal agent treatment, patients 3, 4, and 6 received between 1 and 14 days of treatment with fluconazole, patient 2 had received 21 days of treatment with fluconazole for a previous C. albicans infection but died from an underlying illness, and patient 5 was treated with fluconazole and then with amphotericin B because of the persistent presence of C. glabrata in the patient's urine. Specific control methods beyond basic handwashing and rational prescription of antibiotics were not instituted, and the rate of instances of isolation of C. glabrata fell to an average of two per month.
Fungal isolates. Single isolates of C. glabrata were available from six patients in the ICU (patients 1 to 4 and 6 and 7), and seven isolates were collected from another patient (patient 5). The isolates were collected during October to early December 1994, with the exception of isolate 30444 (patient 7), which was recovered 1 year previously when the patient was in the same unit. As controls, 11 isolates from six epidemiologically unrelated patients were selected from collections made during 1983 to 1985, and a reference culture isolate, ATCC 90030, was also included. Species identification was initially performed with CHROMagar differential culture medium (14) and then was confirmed with the API 20C AUX system (Biomerieux, Basingstoke, Hants, United Kingdom). Cultures were maintained on Oxoid Sabouraud dextrose agar (Unipath, Basingstoke, Hants, United Kingdom). Details of the isolates are listed in Table 1 .
For analysis, cells were grown in YEPD broth (0.3% yeast extract, 1% mycological peptone, 2% glucose [Oxoid]); a loopful of cells was inoculated into 5 ml of broth and incubated at 37ЊC in an orbital incubator at 140 rpm.
DNA extraction. DNA was extracted from 1.5 ml of overnight culture by an adaptation of the methods of Scherer and Stevens (17) . After the cells were pelleted by centrifugation, they were washed and then resuspended in 1 ml of 1 M sorbitol-50 mM potassium phosphate (KH 2 PO 4 ) buffer (pH 7.5). Each extract had 50 l of Zymolyase 20T (ICN Biomedicals, High Wycombe, United Kingdom) at 8 mg/ml and 3 l of ␤-mercaptoethanol added, and this mixture was incubated at 37ЊC for 120 min. The spheroplasts were collected by centrifugation and resuspended in 0.5 ml of GES reagent (5 M guanidium thiocyanate-100 mM EDTA-0.5% Sarkosyl) and kept at room temperature for 20 min (15) . Following the addition of 100 l of 5 M potassium acetate and incubation on ice for 20 min, 0.5 ml of chloroform-pentanol (24:1, vol/vol) was added, the mixture was mixed, and the phases were separated by centrifugation. The upper aqueous layer was removed, and DNA was precipitated by the addition of 0.5 ml of ethanol. The DNA was pelleted, rinsed with 70% ethanol, and resuspended in 100 l of TE buffer (10 mM Tris, 1 mM EDTA). The DNA was reprecipitated, and the final pellet was dissolved in 50 l of TE buffer.
Restriction digests and Southern blots. Restriction digests were performed according to the manufacturers' instructions, with 25 l of DNA solution being used and incubation taking place at 37ЊC for 2.5 h with either EcoRI or MspI or for 4 h with HinfI. The DNA fragments were separated electrophoretically in a 0.8% agarose gel in TBE buffer (0.089 M Trizma base, 2.5 mM EDTA, 32 mM boric acid) at 30 V for 18 h. The DNA was stained with ethidium bromide, and the results were recorded photographically.
The gels were Southern blotted onto flash prime nylon membranes (Stratagene, Cambridge, United Kingdom) by the method of Maniatis et al. (13) , and the DNA was fixed by UV irradiation.
DNA hybridization. Hybridizations with a poly(dG-dT) probe (Pharmacia, St. Albans, Herts, United Kingdom) were conducted at 42ЊC. The blots were prehybridized for 4 h in a mixture of 50% formamide, 5ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate), 5ϫ Denhardt's solution, and 8% fat-free UHT milk. Hybridizations were performed for 18 h in a mixture of 40% formamide, 5ϫ SSC, 1ϫ Denhardt's solution, 5% dextran sulfate, 8% fat-free UHT milk, and heat-denatured, biotin-labelled poly(dG-dT) probe. The membranes were washed five times for 30 min each time in 2ϫ SSC, and hybridization was detected with the BRL BluGENE kit (Gibco BRL, Paisley, Scotland) according to the manufacturer's instructions.
PFGE. Cells were prepared for pulsed-field gel electrophoresis (PFGE) by removing half a loopful of cells from an overnight culture grown on Sabouraud dextrose agar and washing the cells in 200 l of LET buffer (10 mM Tris, 0.5 M EDTA, 2% sodium hydroxide). The cells were pelleted and suspended in 200 l of LET buffer containing 5 mg of Zymolyase 20T per ml. A 250-l aliquot of 1% low-melting-temperature agarose was added, and the solution was pipetted into molds. The agarose plugs were then placed into 1 ml of LET buffer containing 60 l of ␤-mercaptoethanol and incubated at 37ЊC for 24 h. The LET buffer was then replaced with 1 ml of NDS buffer (10 mM Tris, 0.5 M EDTA, 2% sodium hydroxide, 1% lauroylsarcosine) containing 2 mg of proteinase K (Boehringer Mannheim, Lewes, East Sussex, United Kingdom) per ml and incubated at 50ЊC for 24 h. The NDS buffer was then replaced with 0.5 M EDTA, and the plugs were stored at 4ЊC.
Karyotyping of the yeast isolates was performed by PFGE with a Pharmacia-LKB Pulsaphor system with a hexagonal electrode array. The electrophoretic separations were performed in a 1% SeaKem agarose gel in 0.5ϫ TBE at 12ЊC, with a pulse time of 120 s at 110 V for 22 h and then a time of 180 s at 110 V for 22 h. The gels were stained with ethidium bromide, and the results were photographed.
RAPD. A 10-mer primer, 5Ј-TGGACCCTGC-3Ј (3), was used in DNA amplification reactions as described by Howell et al. (6) . Briefly, 200 M (each) deoxynucleotides (Sigma), 1 M primer, 100 ng of extracted genomic DNA, 2 U of Dynazyme (Flowgen, Staffordshire, United Kingdom), 5 l of 10ϫ reaction buffer, and 1.5 mM magnesium chloride were added to a 50-l reaction volume, and the volume was made up to 50 l with molecular biology-grade water. The cycling parameters were 94ЊC for 5 s, 36ЊC for 30 s, and 72ЊC for 1 min for 30 cycles on a Hybaid OmniGene using tube control. A 10-l aliquot of the random amplification of polymorphic DNA (RAPD) assay mixture was electrophoresed on a 2% agarose gel in TBE buffer at 70 V for 3 h; the gels were then stained with ethidium bromide and photographed.
Susceptibility tests. Antifungal agent susceptibility tests were done by an in-house broth microdilution method (13a), with twofold serial dilutions of fluconazole in water (0.06 to 128 g/ml) and itraconazole in dimethyl sulfoxide (0.06 to 32 g/ml) being used. The inoculum was prepared from an overnight culture grown on Sabouraud dextrose agar and appropriately diluted in yeast nitrogen base broth (Unipath). The trays were incubated at 35ЊC for 48 h, and the MIC was determined as the drug concentration that reduced growth by 80% compared with growth of the drug-free control. The breakpoint for resistance to fluconazole was a concentration of 8 to 32 g/ml, and that for resistance to itraconazole was a concentration of 2 to 8 g/ml.
The susceptibilities of the ICU isolates were confirmed by the Bristol Mycology Reference Laboratory by a broth microdilution assay (7).
RESULTS
The ICU isolates, the American Type Culture Collection strain, and the isolates from outpatients 8, 10, 11, and 13 produced the same API 20C AUX profile, 2000040. Those from outpatients 9 and 12 additionally utilized glycine and produced a profile code of 6000040. There was no apparent association between the API profile and any of the DNA typing schemes.
Few differences in the restriction patterns obtained with EcoRI were seen, with ICU isolates 5412 (patient 3) and 45618 (patient 4) providing one pattern and with all of the remaining isolates, including the outpatient strains, giving a second pattern. MspI provided better discrimination and produced six patterns from the seven ICU patients' isolates, again with isolates 5412 and 45618 being indistinguishable. However, both of these restriction enzymes produce a large number of bands and a high background which hinders interpretation; therefore, a third enzyme, HinfI, was used, and this enzyme revealed a series of very distinct bands in the region from 23 kb to approximately 4.4 kb. These bands indicated that isolates 5412 and 45618 could not be distinguished and that the remaining five ICU patients and six outpatients each carried a separate and individual strain. In cases in which multiple isolates were available from the same patients, it was found that single band differences could be seen within the patterns, which typically comprised six or seven bands (Fig. 1) . Between patients, however, the differences amounted to several bands (Fig. 2) . A difference of one band was not considered sufficient reason to designate an isolate as a separate strain; therefore, patients 5, 8, 12, and 13 were found to harbor two subtypes of single strains (subtypes indicated in Table 1 ). With HinfI, a total of 13 patterns were identified from isolates from 13 patients and one reference strain.
Southern hybridizations of the poly(dG-dT) probe to DNA digested with either EcoRI or MspI revealed between four and seven bright bands plus some that were fainter (Fig. 3) . Four different patterns among the samples from the ICU were detected with both enzymes. A further three patterns were de- tected among samples from the control outpatients when EcoRI was used.
Comparisons of chromosome bands that had sizes of less than 1.6 Mb and that were separated by PFGE distinguished isolates from five patients (1, 2, 3, 5, and 6) from the ICU and showed that the multiple isolates from patient 5 were indistinguishable from each other and that from patient 7. Isolates 5412 (patient 3) and 45618 (patient 4) appeared to be very similar. Among 12 outpatient isolates examined, representing six patients and one reference culture, five karyotype patterns were detected, one of which resembled the pattern from patient 5 (data summarized in Table 1 ). A total of nine patterns from isolates from 13 patients and the reference strain were identified.
RAPD typing results were similar to those obtained by PFGE. Strains with a difference of two or more bands were considered distinct. Multiple isolates from patient 5 were indistinguishable, and isolates 5412 (patient 3) and 45618 (patient 4) produced identical fingerprints. All other isolates from the ICU had unique RAPD fingerprints. Six distinct patterns were obtained from the 12 control isolates (six patients and one type culture). One pattern resembled the fingerprint obtained for patients 3 and 4, and the pattern for the reference strain (ATCC 90030) was indistinguishable from that for the isolate from patient 2 ( Fig. 4 and Table 1 
DISCUSSION
Following a sudden and short-lived increase in the recovery of C. glabrata isolates from the skin and urine of patients in an ICU, the isolates were examined by DNA typing methods to establish if an outbreak had occurred and which methods would be the most suitable to examine strains of this species.
For REA, the enzyme HinfI proved to be the most discriminatory enzyme for the separation of these C. glabrata isolates. These results suggested that patients 3 and 4 (isolates 5412 and 45618 were recovered only 5 days apart) may have shared a single strain but that the remaining five patients in the ICU were infected with distinct strains. The epidemiologically unrelated outpatient isolates acted as controls for the comparisons with the ICU isolates, and each of these outpatients carried a separate, distinguishable strain. The enzyme EcoRI failed to discriminate among isolates, while MspI distinguished six of the seven patient isolates. Similar findings were reported by Reagan et al. (16) , who detected two patterns among six isolates with either BstI or EcoRI, and Lee et al. (11), who could not distinguish among 25 isolates with EcoRI but who detected five types with XbaI. However, Vazquez et al. (19) differentiated 34 isolates into 14 groups with EcoRI and further subdivided 3 of these groups with MspI.
Hybridization of genomic blots with suitable probes provides one approach to improving the discrimination achieved by REA. The simple repeat sequence poly(dG-dT) has been used as a probe to differentiate strains of C. albicans (20) , and in this study of C. glabrata, it was used to detect seven patterns from 13 patients. Sullivan et al. (18) tested a selection of simple repeat oligonucleotide probes for the differentiation of 12 C. glabrata isolates and described (G-T) 8 as being the most informative, providing four patterns.
Karyotyping is another method that has been useful in the identification of strains of C. glabrata. Kaufmann (1) examined 21 isolates of C. glabrata and detected 6 to 12 bands in the size range of 0.42 to 2.4 Mb, with one or two bands being highly variable in size. These variable bands hybridized to a ribosomal DNA (rDNA) probe that hybridizes to C. albicans. The bands below the rDNA chromosomes were similar, although there were a few bands in each karyotype that enabled the isolates to be distinguished. The chromosomes bearing the rDNA were reported to exhibit clonal variation, and the authors concluded that karyotyping offered a precise identification method if the variable bands were ignored. As hybridization with an rDNA probe confirmed the nature of the heaviest bands in this study (data not shown), bands larger than 1.6 Mb were not included in the analysis of the karyotypes of the isolates in our study. This cutoff enabled five strains from the ICU patients to be recognized, with the multiple isolates from patient 5 being identical.
The last DNA typing method examined used RAPD, as this technique has proven useful for the typing of strains of C. albicans (2, 6) and C. glabrata (3, 12) and has been considered to be highly discriminatory, reproducible, rapid, and relatively simple. Although primer A3 used in this study was not as discriminatory as HinfI in REA, other primers may improve discrimination. Bostock et al. (2) described two primers for RAPD analysis, of which one was more discriminatory and one less discriminatory compared with those for REA.
In conclusion, the typing technique found to be most suitable for the differentiation of isolates of C. glabrata was REA with HinfI, which detected 13 strains from 14 sources. PFGE and RAPD were not as discriminatory as REA, although both detected nine types from the 14 sources; however, these two typing schemes did not correlate in several instances.
These methods demonstrated that what had initially appeared to be an outbreak of C. glabrata in an ICU because of the unusual number of isolates and time clustering of their isolation was not due to cross-infection, as five of the seven patients had distinguishable strains. The two patients with indistinguishable isolates could represent an example of crossinfection or simply reflect the existence of a common type. Normal infection control procedures were instituted, and there have been few isolates of this yeast species recovered since this episode.
